Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Obstructive Lung Diseases

  Free Subscription


22.04.2024

1 Am J Med
1 Am J Respir Cell Mol Biol
13 Am J Respir Crit Care Med
2 Ann Allergy Asthma Immunol
1 Arch Bronconeumol
1 Arch Dis Child
1 Clin Exp Allergy
7 Eur Respir J
4 J Asthma
2 PLoS One
1 Respir Med
4 Respir Res
1 Rev Mal Respir
2 Thorax


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Med

  1. MARTIN D, Cobb JK, Gross CA
    The Boldness of the Biopsy in a Case of Organizing Pneumonia.
    Am J Med. 2024;137:308-310.
    PubMed        


    Am J Respir Cell Mol Biol

  2. SHARMA S, Gerber AN, Kraft M, Wenzel SE, et al
    Asthma Pathogenesis: Phenotypes, Therapies and Gaps. Summary of the Aspen Lung Conference 2023.
    Am J Respir Cell Mol Biol. 2024 Apr 18. doi: 10.1165/rcmb.2024-0082.
    PubMed         Abstract available


    Am J Respir Crit Care Med

  3. GRAUL EL, Nordon C, Rhodes K, Marshall J, et al
    Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based Study.
    Am J Respir Crit Care Med. 2024;209:960-972.
    PubMed         Abstract available

  4. VERLEDEN SE, Hendriks JMH, Lapperre TS
    Reply to Polverino: Clearing the Air: Innovations in Imaging for Early Detection and Management of Chronic Obstructive Pulmonary Disease.
    Am J Respir Crit Care Med. 2024;209:1044-1045.
    PubMed        

  5. POLVERINO F
    Clearing the Air: Innovations in Imaging for Early Detection and Management of Chronic Obstructive Pulmonary Disease.
    Am J Respir Crit Care Med. 2024;209:1042-1043.
    PubMed        

  6. CHAN ED
    Identification of Alpha-1 Antitrypsin-Deficient Subjects with Normal Spirometry Who May Benefit from Alpha-1 Antitrypsin Replacement.
    Am J Respir Crit Care Med. 2024;209:1033-1034.
    PubMed        

  7. WILLIAMS PJ, Buttery SC, Laverty AA, Hopkinson NS, et al
    Lung Disease and Social Justice: Chronic Obstructive Pulmonary Disease as a Manifestation of Structural Violence.
    Am J Respir Crit Care Med. 2024;209:938-946.
    PubMed         Abstract available

  8. BHATT SP, Bodduluri S, Nakhmani A, Oelsner EC, et al
    Unadjusted Lower Limit of Normal for Airflow Obstruction.
    Am J Respir Crit Care Med. 2024;209:1028-1030.
    PubMed        

  9. RITTAYAMAI N, Marinpong V, Chuaychoo B, Tscheikuna J, et al
    Ultrasound Evaluation of Parasternal Intercostal, Diaphragm Activity, and Their Ratio in Male Patients with Chronic Obstructive Pulmonary Disease.
    Am J Respir Crit Care Med. 2024;209:1016-1018.
    PubMed        

  10. BEGHE B, Spanevello A, Fabbri LM
    Risk and Prevention of Cardiovacular Events after Exacerbations of Respiratory Symptoms in Patients with COPD.
    Am J Respir Crit Care Med. 2024;209:901-902.
    PubMed        

  11. AARON SD, Montes de Oca M, Celli B, Bhatt SP, et al
    Early Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease: The Costs and Benefits of Case Finding.
    Am J Respir Crit Care Med. 2024;209:928-937.
    PubMed        

  12. DOUGHERTY GW, Ostrowski LE, Nothe-Menchen T, Raidt J, et al
    Recessively Inherited Deficiency of Secreted WFDC2 (HE4) Causes Nasal Polyposis and Bronchiectasis.
    Am J Respir Crit Care Med. 2024 Apr 16. doi: 10.1164/rccm.202308-1370.
    PubMed         Abstract available

  13. MILLS DR, Masters IB, Yerkovich ST, McEniery J, et al
    Radiographic Outcomes in Paediatric Bronchiectasis and Factors Associated with Reversibility.
    Am J Respir Crit Care Med. 2024 Apr 17. doi: 10.1164/rccm.202402-0411.
    PubMed         Abstract available

  14. DJUKANOVIC R, Brinkman P, Kolmert J, Gomez C, et al
    Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic, Omalizumab, in Severe Asthma in Adults: Results of the SoMOSA Study.
    Am J Respir Crit Care Med. 2024 Apr 18. doi: 10.1164/rccm.202310-1730.
    PubMed         Abstract available

  15. PIETERS ALP PIETERS, van der Veer T, Meerburg JJ, Andrinopoulou ER, et al
    Structural Lung Disease and Clinical Phenotype in Bronchiectasis Patients: The EMBARC CT Study.
    Am J Respir Crit Care Med. 2024 Apr 18. doi: 10.1164/rccm.202311-2109.
    PubMed         Abstract available


    Ann Allergy Asthma Immunol

  16. TURI KN, Li Y, Xu Y, Gebretsadik T, et al
    The Association of Infant Urinary Adrenal Steroids with the Risk of Childhood Asthma Development.
    Ann Allergy Asthma Immunol. 2024 Apr 15:S1081-1206(24)00215.
    PubMed         Abstract available

  17. WOO SD, Park HS, Yang EM, Ban GY, et al
    8-Iso-prostaglandin F2alpha as a biomarker of T2-low airway inflammation and remodeling in adult asthma.
    Ann Allergy Asthma Immunol. 2024 Apr 12:S1081-1206(24)00214.
    PubMed         Abstract available


    Arch Bronconeumol

  18. GAO YH, Zhu YN, Bai JW, Liang S, et al
    Severe Pulmonary Hypertension Increased All-cause Mortality in Patients With Bronchiectasis.
    Arch Bronconeumol. 2024 Mar 23:S0300-2896(24)00073.
    PubMed        


    Arch Dis Child

  19. HANNAH R, Chavasse RJPG, Paton JY, Walton E, et al
    Emergency department discharge practices for children with acute wheeze and asthma: a survey of discharge practice and review of safety netting instructions in the UK and Ireland.
    Arch Dis Child. 2024 Apr 16:archdischild-2023-326247.
    PubMed         Abstract available


    Clin Exp Allergy

  20. GEORGAKOU AV, Ekstrom S, Andersson N, Hallberg J, et al
    Mediterranean-type diet in school age in relation to asthma and lung function up to young adulthood.
    Clin Exp Allergy. 2024 Apr 14. doi: 10.1111/cea.14483.
    PubMed        


    Eur Respir J

  21. VARRICCHI G, Brightling CE, Grainge C, Lambrecht BN, et al
    Airway remodelling in asthma and the epithelium: on the edge of a new era.
    Eur Respir J. 2024;63:2301619.
    PubMed         Abstract available

  22. ALIBERTI S, Ringshausen FC, Dhar R, Haworth CS, et al
    Objective sputum colour assessment and clinical outcomes in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
    Eur Respir J. 2024;63:2301554.
    PubMed         Abstract available

  23. HATTER L, Holliday M, Eathorne A, Bruce P, et al
    The carbon footprint of as-needed budesonide-formoterol in mild asthma: a post hoc analysis.
    Eur Respir J. 2024 Apr 12:2301705. doi: 10.1183/13993003.01705-2023.
    PubMed         Abstract available

  24. SPINOU A, Hererro-Cortina B, Aliberti S, Goeminne PC, et al
    Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
    Eur Respir J. 2024 Apr 12:2301689. doi: 10.1183/13993003.01689-2023.
    PubMed         Abstract available

  25. STANESCU C, Talarico R, Weichenthal S, Villeneuve PJ, et al
    Early life exposure to pollens and increased risks of childhood asthma: a prospective cohort study in Ontario children.
    Eur Respir J. 2024;63:2301568.
    PubMed         Abstract available

  26. TANG RD, Yue JQ, Guan WJ
    Sputum colour as a simplified effective biomarker for clinical assessment of bronchiectasis.
    Eur Respir J. 2024;63:2400152.
    PubMed        


  27. "Therapeutic improvement of CFTR function and reversibility of bronchiectasis in cystic fibrosis." M.O. Wielputz and M.A. Mall. Eur Respir J 2024; 63: 2400234.
    Eur Respir J. 2024;63:2450234.
    PubMed        


    J Asthma

  28. FAN IM, Goh S, Choi J, Tan DJ, et al
    Spontaneous pneumomediastinum and pneumopericardium in a young male with asthma.
    J Asthma. 2024 Apr 19:1-6. doi: 10.1080/02770903.2024.2346151.
    PubMed         Abstract available

  29. GARCIA MS, Serrano CC, Martin Hernandez AS, Eiros Bachiller JM, et al
    Mounier-Kuhn Syndrome in poorly controlled asthma.
    J Asthma. 2024 Apr 19:1-8. doi: 10.1080/02770903.2024.2344168.
    PubMed         Abstract available

  30. WIECZOREK K, Ananth S, Valazquez-Pimentel D
    Acoustic biomarkers in asthma: a systematic review.
    J Asthma. 2024 Apr 18:1-18. doi: 10.1080/02770903.2024.2344156.
    PubMed         Abstract available

  31. JIANG S, Zhou Y, Gao J, Jin S, et al
    Urinary Metabolomic Profiles Uncover Metabolic Pathways in Children with Asthma.
    J Asthma. 2024 Apr 18:1-11. doi: 10.1080/02770903.2024.2338865.
    PubMed         Abstract available


    PLoS One

  32. LIU L, Chen Y, He G, Lin B, et al
    Exploring the impact of OSA on short-term survival in patients with AECOPD admitted to the ICU.
    PLoS One. 2024;19:e0301646.
    PubMed         Abstract available

  33. DA SILVA NC, Malagutti BC, Ladeira JMCD, Grotta MB, et al
    Pathophysiology of non-cystic fibrosis bronchiectasis in children and adolescents with asthma: A protocol for systematic review and meta-analysis.
    PLoS One. 2024;19:e0294921.
    PubMed         Abstract available


    Respir Med

  34. CANONICA GW, Domingo C, Lavoie KL, Kaliasethi A, et al
    Asthma patients' and physicians' perspectives on the burden and management of asthma: post-hoc analysis of APPaRENT 1 and 2 to assess predictors of treatment adherence.
    Respir Med. 2024 Apr 16:107637. doi: 10.1016/j.rmed.2024.107637.
    PubMed         Abstract available


    Respir Res

  35. LIU Y, Chen F, Zeng Z, Lei C, et al
    Neopterin in patients with COPD, asthma, and ACO: association with endothelial and lung functions.
    Respir Res. 2024;25:171.
    PubMed         Abstract available

  36. KOVACH MA, Kack U, Che KF, Brundin B, et al
    Systemic IL-26 correlates with improved asthma control in children sensitized to dog allergen.
    Respir Res. 2024;25:163.
    PubMed         Abstract available

  37. GAO J, Yang Y, Xiang X, Zheng H, et al
    Human genetic associations of the airway microbiome in chronic obstructive pulmonary disease.
    Respir Res. 2024;25:165.
    PubMed         Abstract available

  38. FUNG NH, Nguyen QA, Owczarek C, Wilson N, et al
    Early-life house dust mite aeroallergen exposure augments cigarette smoke-induced myeloid inflammation and emphysema in mice.
    Respir Res. 2024;25:161.
    PubMed         Abstract available


    Rev Mal Respir

  39. RAASCH K, Dupin I
    [Modifications of distal pathways in COPD, in light of recent technological advances in imaging and transcriptomics].
    Rev Mal Respir. 2024;41:269-273.
    PubMed         Abstract available


    Thorax

  40. JENKINS AR, Burtin C, Camp PG, Lindenauer P, et al
    Do pulmonary rehabilitation programmes improve outcomes in patients with COPD posthospital discharge for exacerbation: a systematic review and meta-analysis.
    Thorax. 2024;79:438-447.
    PubMed         Abstract available

  41. WU T, Santos S, Quezada-Pinedo HG, Vernooij MW, et al
    Body composition and respiratory outcomes in children: a population-based prospective cohort study.
    Thorax. 2024;79:448-456.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.